...
机译:环磷酰胺联合泼尼松龙治疗的MPO-ANCA相关血管炎患者的健康相关生活质量改善:来自JMAAV研究的18个月随访数据分析
Department of Public Health and Environmental Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-8461, Japan;
Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan;
Division of Internal Medicine, Juntendo University Koshigaya Hospital, Koshigaya, Japan;
Division of Rheumatology, Niigata Rheumatic Center, Niigata, Japan;
Department of Nephrology, Jichi Medical University, Shimotsuke, Japan;
Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan;
Birmingham Vasculitis Activity Score (BVAS); MOS Short-Form 36-Item Health Survey (SF-36); MPO-ANCA-associated vasculitis; Japan;
机译:环磷酰胺联合泼尼松龙治疗的MPO-ANCA相关血管炎患者的健康相关生活质量改善:来自JMAAV研究的18个月随访数据分析
机译:接受根治性放疗的前列腺癌患者中,雄激素受体抑制剂单药治疗比去势加雄激素受体抑制剂对性兴趣更高,但与健康相关的生活质量差异却很小:一项为期18个月的随机前瞻性随访研究
机译:JMAAV研究对日本MPO-ANCA相关血管炎患者进行基于严重度的治疗
机译:使用与健康相关的生活质量数据对间质分析数据进行聚类
机译:评估接受化学疗法治疗的小动物癌症患者健康相关生活质量(HRQOL)的调查。
机译:JMAAV研究对日本MPO-ANCA相关血管炎患者进行基于严重度的治疗
机译:日本MPO-ANCA相关血管炎患者的严重程度治疗:JMAAV研究